A full explanation of the study, including possible benefits and risks, is presented in the “Participant Information Sheet/Consent Form,” which can be downloaded below.
These forms have been approved by the Human Research Ethics Committee (HREC) of Monash Health (Melbourne, Victoria, Australia).
- For potential participants who are adults (aged 18 years or over)
- For parents/guardians of potential participants (aged 14 years or over)
The study is prospectively registered (ACTRN12620000890932; UTN: U1111-1256-5457) on the Australian New Zealand Clinical Trials Registry (ANZCTR); click here for full details.
Articles and Media
You can read more about our past TMS research in autism below. Please email us if you would like to receive any of these full articles.
Brain Stimulation Holds Promise in Autism Treatment, Newsweek, 2015.
Magnetic promise: Can brain stimulation treat autism? Spectrum, 2015.
The Potential of Repetitive Transcranial Magnetic Stimulation for Autism Spectrum Disorder: A Consensus Statement, Biological Psychiatry, 2019.
Transcranial magnetic stimulation (TMS) therapy for autism: an international consensus conference held in conjunction with the international meeting for autism research on May 13th and 14th, 2014, Frontiers in Human Neuroscience, 2015.